Close Menu

NEW YORK (GenomeWeb) – Blood-based cancer detection firm Thrive Earlier Detection announced its launch today, supported by a $110 million financing round.

The Cambridge, Massachusetts-based firm plans to commercialize a circulating tumor DNA and protein testing method initially developed at Johns Hopkins University and currently being validated in a 10,000-person trial with Pennsylvania's Gesinger Health system.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.